Not a radiosensitizing drug –
**Core Concept**
Radiosensitization is a process where a drug enhances the sensitivity of cancer cells to radiation therapy, making it easier to kill them. This concept is crucial in oncology, as it helps in delivering effective treatment with reduced side effects.
**Why the Correct Answer is Right**
The correct answer is a drug that does not enhance the effect of radiation therapy. One such example is **Cyclophosphamide**. Cyclophosphamide is an alkylating agent used in chemotherapy, but it does not have radiosensitizing properties. It works by interfering with DNA replication and preventing cancer cells from dividing and growing.
**Why Each Wrong Option is Incorrect**
**Option A:** **Hydroxyurea** is actually a radiosensitizer. It inhibits ribonucleotide reductase, an enzyme required for DNA synthesis, making cancer cells more susceptible to radiation.
**Option B:** **Cisplatin** is also a radiosensitizer. It works by cross-linking DNA, causing damage to cancer cells and making them more sensitive to radiation.
**Option C:** **5-Fluorouracil (5-FU)** has radiosensitizing properties as well. It inhibits thymidylate synthase, an enzyme required for DNA synthesis, making cancer cells more vulnerable to radiation.
**Clinical Pearl / High-Yield Fact**
When using chemotherapy and radiation therapy together, it's essential to choose drugs that have radiosensitizing properties to enhance the treatment's effectiveness. This combination is often referred to as chemoradiation.
**Correct Answer:** D. Cyclophosphamide